Loren Keith Henry, Ph.D - Publications

Affiliations: 
1994-2000 Cellular, Molecular and Developmental Biology University of Tennessee, Knoxville, Knoxville, TN, United States 
 2000-2008 Pharmacology VANDERBILT UNIVERSITY MEDICAL CTR, Nashville, TN, United States 
 2008- Basic Sciences Univeristy of North Dakota 
Area:
monoamine neurotransmitter transporters, serotonin, dopamine, drugs of abuse, epigenetics
Website:
http://henrylab.org

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Richardson BD, Saha K, Krout D, Cabrera E, Felts B, Henry LK, Swant J, Zou MF, Newman AH, Khoshbouei H. Membrane potential shapes regulation of dopamine transporter trafficking at the plasma membrane. Nature Communications. 7: 10423. PMID 26804245 DOI: 10.1038/ncomms10423  0.96
2015 Kumar V, Yarravarapu N, Lapinsky DJ, Perley D, Felts B, Tomlinson MJ, Vaughan RA, Henry LK, Lever JR, Newman AH. Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram. Journal of Medicinal Chemistry. PMID 26153715 DOI: 10.1021/acs.jmedchem.5b00682  0.96
2014 Bowton E, Saunders C, Reddy IA, Campbell NG, Hamilton PJ, Henry LK, Coon H, Sakrikar D, Veenstra-VanderWeele JM, Blakely RD, Sutcliffe J, Matthies HJ, Erreger K, Galli A. SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking. Translational Psychiatry. 4: e464. PMID 25313507 DOI: 10.1038/tp.2014.90  0.96
2014 Dahal RA, Pramod AB, Sharma B, Krout D, Foster JD, Cha JH, Cao J, Newman AH, Lever JR, Vaughan RA, Henry LK. Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding site. The Journal of Biological Chemistry. 289: 29712-27. PMID 25179220 DOI: 10.1074/jbc.M114.571521  0.96
2014 Felts B, Pramod AB, Sandtner W, Burbach N, Bulling S, Sitte HH, Henry LK. The two Na+ sites in the human serotonin transporter play distinct roles in the ion coupling and electrogenicity of transport. The Journal of Biological Chemistry. 289: 1825-40. PMID 24293367 DOI: 10.1074/jbc.M113.504654  0.96
2014 Gaffaney JD, Shetty M, Felts B, Pramod AB, Foster JD, Henry LK, Vaughan RA. Antagonist-induced conformational changes in dopamine transporter extracellular loop two involve residues in a potential salt bridge. Neurochemistry International. 73: 16-26. PMID 24269640 DOI: 10.1016/j.neuint.2013.11.003  0.96
2014 Beckman ML, Pramod AB, Perley D, Henry LK. Stereoselective inhibition of serotonin transporters by antimalarial compounds. Neurochemistry International. 73: 98-106. PMID 24161619 DOI: 10.1016/j.neuint.2013.10.009  0.96
2013 Pramod AB, Foster J, Carvelli L, Henry LK. SLC6 transporters: structure, function, regulation, disease association and therapeutics. Molecular Aspects of Medicine. 34: 197-219. PMID 23506866 DOI: 10.1016/j.mam.2012.07.002  0.96
2011 Henry LK, Iwamoto H, Field JR, Kaufmann K, Dawson ES, Jacobs MT, Adams C, Felts B, Zdravkovic I, Armstrong V, Combs S, Solis E, Rudnick G, Noskov SY, DeFelice LJ, et al. A conserved asparagine residue in transmembrane segment 1 (TM1) of serotonin transporter dictates chloride-coupled neurotransmitter transport. The Journal of Biological Chemistry. 286: 30823-36. PMID 21730057 DOI: 10.1074/jbc.M111.250308  0.96
2011 Thompson BJ, Jessen T, Henry LK, Field JR, Gamble KL, Gresch PJ, Carneiro AM, Horton RE, Chisnell PJ, Belova Y, McMahon DG, Daws LC, Blakely RD. Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter. Proceedings of the National Academy of Sciences of the United States of America. 108: 3785-90. PMID 21282638 DOI: 10.1073/pnas.1011920108  0.96
2011 Thompson BJ, Jessen T, Henry LK, Field JR, Gamble KL, Gresch PJ, Carneiro AM, Horton RE, Chisnell PJ, Belova Y, McMahon DG, Daws LC, Blakely RD. Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter (Proceedings of the National Academy of Sciences of the United States of America (2011) 108, 9, (3785-3790) DOI: 10.1073/pnas.1011920108) Proceedings of the National Academy of Sciences of the United States of America. 108: 6689. DOI: 10.1073/pnas.1104147108  0.96
2010 Field JR, Henry LK, Blakely RD. Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamine. The Journal of Biological Chemistry. 285: 11270-80. PMID 20159976 DOI: 10.1074/jbc.M109.093658  0.96
2009 Kaufmann KW, Dawson ES, Henry LK, Field JR, Blakely RD, Meiler J. Structural determinants of species-selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studies. Proteins. 74: 630-42. PMID 18704946 DOI: 10.1002/prot.22178  0.96
2008 Henry LK, Blakely RD. Distinctions between dopamine transporter antagonists could be just around the bend. Molecular Pharmacology. 73: 616-8. PMID 18156312 DOI: 10.1124/mol.107.044586  0.96
2007 Henry LK, Meiler J, Blakely RD. Bound to be different: neurotransmitter transporters meet their bacterial cousins. Molecular Interventions. 7: 306-9. PMID 18199851 DOI: 10.1124/mi.7.6.4  0.96
2006 Henry LK, Defelice LJ, Blakely RD. Getting the message across: a recent transporter structure shows the way. Neuron. 49: 791-6. PMID 16543127 DOI: 10.1016/j.neuron.2006.03.002  0.96
2006 Henry LK, Field JR, Adkins EM, Parnas ML, Vaughan RA, Zou MF, Newman AH, Blakely RD. Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants. The Journal of Biological Chemistry. 281: 2012-23. PMID 16272152 DOI: 10.1074/jbc.M505055200  0.96
2003 Henry LK, Adkins EM, Han Q, Blakely RD. Serotonin and cocaine-sensitive inactivation of human serotonin transporters by methanethiosulfonates targeted to transmembrane domain I. The Journal of Biological Chemistry. 278: 37052-63. PMID 12869570 DOI: 10.1074/jbc.M305514200  0.96
2002 Henry LK, Khare S, Son C, Babu VV, Naider F, Becker JM. Identification of a contact region between the tridecapeptide alpha-factor mating pheromone of Saccharomyces cerevisiae and its G protein-coupled receptor by photoaffinity labeling. Biochemistry. 41: 6128-39. PMID 11994008 DOI: 10.1021/bi015863z  0.96
2000 Liu S, Henry LK, Lee BK, Wang SH, Arshava B, Becker JM, Naider F. Position 13 analogs of the tridecapeptide mating pheromone from Saccharomyces cerevisiae: design of an iodinatable ligand for receptor binding. The Journal of Peptide Research : Official Journal of the American Peptide Society. 56: 24-34. PMID 10917454 DOI: 10.1034/j.1399-3011.2000.00730.x  0.96
1998 Lay J, Henry LK, Clifford J, Koltin Y, Bulawa CE, Becker JM. Altered expression of selectable marker URA3 in gene-disrupted Candida albicans strains complicates interpretation of virulence studies. Infection and Immunity. 66: 5301-6. PMID 9784536  0.96
1995 Becker JM, Henry LK, Jiang W, Koltin Y. Reduced virulence of Candida albicans mutants affected in multidrug resistance. Infection and Immunity. 63: 4515-8. PMID 7591094  0.96
1995 Bulawa CE, Miller DW, Henry LK, Becker JM. Attenuated virulence of chitin-deficient mutants of Candida albicans. Proceedings of the National Academy of Sciences of the United States of America. 92: 10570-4. PMID 7479842 DOI: 10.1073/pnas.92.23.10570  0.96
Show low-probability matches.